Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Stacy

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|March 26, 2008
Extraocular muscle dystonia due to acquired (non-Wilsonian) hepatocerebral degenerationJoseph Ferrara, Deepak Gupta, Emily Foster, et al.
Patient Related Outcome Measures|December 4, 2012
Patient perspectives on Parkinson's disease therapy in Japan and the United States: results of two patient surveysNobutaka Hattori, Kenichi Fujimoto, Tomoyoshi Kondo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 13, 2010
Early treatment benefits of ropinirole prolonged release in Parkinson's disease patients with motor fluctuationsBonnie P Hersh, Nancy L Earl, Robert A Hauser, et al.
Clinical Neuropharmacology|November 4, 2008
Impulse control disorders arising in 3 patients treated with rotigotineThomas S Wingo, Marian Evatt, Burton Scott, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 27, 2009
Motor learning in essential tremorHolly A Shill, Frederick J De La Vega, Johan Samanta, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 6, 2014
Clinical spectrum of impulse control disorders in Parkinson's diseaseDaniel Weintraub, Anthony S David, Andrew H Evans, et al.
Parkinsonism & Related Disorders|October 18, 2011
Istradefylline for Parkinson's disease patients experiencing motor fluctuations: results of the KW-6002-US-018 studyEmmanuelle Pourcher, Hubert H Fernandez, Mark Stacy, et al.
Clinical Neuropharmacology|November 11, 2006
End-of-dose wearing off in Parkinson disease: a 9-question survey assessmentMark Stacy, Robert Hauser, Wolfgang Oertel, et al.
Familial Cancer|May 14, 2013
Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registryMurray Joseph Casey, Chhanda Bewtra, Henry T Lynch, et al.
Journal of the Neurological Sciences|January 18, 2015
Primary results from the cervical dystonia patient registry for observation of onabotulinumtoxina efficacy (CD PROBE)Joseph Jankovic, Charles H Adler, David Charles, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Movement Disorders : Official Journal of the Movement Disorder Society|March 26, 2008
Extraocular muscle dystonia due to acquired (non-Wilsonian) hepatocerebral degenerationJoseph Ferrara, Deepak Gupta, Emily Foster, et al.
Patient Related Outcome Measures|December 4, 2012
Patient perspectives on Parkinson's disease therapy in Japan and the United States: results of two patient surveysNobutaka Hattori, Kenichi Fujimoto, Tomoyoshi Kondo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 13, 2010
Early treatment benefits of ropinirole prolonged release in Parkinson's disease patients with motor fluctuationsBonnie P Hersh, Nancy L Earl, Robert A Hauser, et al.
Clinical Neuropharmacology|November 4, 2008
Impulse control disorders arising in 3 patients treated with rotigotineThomas S Wingo, Marian Evatt, Burton Scott, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 27, 2009
Motor learning in essential tremorHolly A Shill, Frederick J De La Vega, Johan Samanta, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 6, 2014
Clinical spectrum of impulse control disorders in Parkinson's diseaseDaniel Weintraub, Anthony S David, Andrew H Evans, et al.
Parkinsonism & Related Disorders|October 18, 2011
Istradefylline for Parkinson's disease patients experiencing motor fluctuations: results of the KW-6002-US-018 studyEmmanuelle Pourcher, Hubert H Fernandez, Mark Stacy, et al.
Clinical Neuropharmacology|November 11, 2006
End-of-dose wearing off in Parkinson disease: a 9-question survey assessmentMark Stacy, Robert Hauser, Wolfgang Oertel, et al.
Familial Cancer|May 14, 2013
Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registryMurray Joseph Casey, Chhanda Bewtra, Henry T Lynch, et al.
Journal of the Neurological Sciences|January 18, 2015
Primary results from the cervical dystonia patient registry for observation of onabotulinumtoxina efficacy (CD PROBE)Joseph Jankovic, Charles H Adler, David Charles, et al.
Pageof 7